Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,62118,640 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

Tumor suppressor p53 plays a central role in tumor prevention. p53 is frequently mutated in human cancer, including colorectal cancer (CRC). Many mutant p53 (mutp53) proteins not o...

$4.5M
USD
Completed TRAINING, INDIVIDUAL
Development of Advanced Oligonucleotides for Glioblastoma Therapeutics
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2021 – 2024

PROJECT SUMMARY Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumor in adults. Despite significant progress being made in characterizing the genet...

$324.5K
USD
Completed NON-SBIR/STTR RPGS
DNA Methylation Markers, Genes and Breast Cancer Risk
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2021 – 2026

PROJECT SUMMARY Genome-wide association studies (GWAS) have identified common variants in ~200 genetic loci associated with breast cancer risk. However, it is difficult to translat...

$6.56M
USD
Completed TRAINING, INDIVIDUAL
Mechanism of Transformation in T-Cell Lymphomas: Identification of Therapeutic Targets
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2024

Project Summary T-cell lymphomas (TCL) are a highly aggressive and heterogeneous group of non-Hodgkin lymphomas derived from post-thymic mature T- and NK-cells. Limited understandi...

$442.3K
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2026

Metastatic prostate cancer (PCa) remains a major clinical challenge. Although androgen deprivation therapy (ADT) is effective in treating PCa, majority of the patients quickly deve...

$3.5M
USD
Completed NON-SBIR/STTR RPGS
Targeting the autophagy-lysosome system to block pancreatic cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY Cancer cells co-opt autophagy - an evolutionarily conserved cellular recycling pathway - to maintain metabolic fitness. Prior studies have shown that Pancreatic Duc...

$3.65M
USD
Completed NON-SBIR/STTR RPGS
Developing newly combined therapeutic strategies for mature B cell lymphoma
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2024

While PD-1 blockade is effective in relapsed or refractory classical Hodgkin lymphoma (cHL) and in a subset of diffuse large B cell lymphomas (DLBCL) patients, a majority of B cell...

$4.52M
USD
Completed NON-SBIR/STTR RPGS
Interplay between tumor and microenvironment in bone metastasis
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2026

Prostate cancer (CaP) is the most commonly diagnosed cancer and the second leading cause of cancer death in men over the age of fifty. Bone is the primary site of metastasis in pat...

$4.62M
USD
Completed NON-SBIR/STTR RPGS
Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary CLL is the most common leukemia of adults in North America, with about 20,000 new cases per year, and remains incurable. Although a small subset of patients has ind...

$6.68M
USD
Completed NON-SBIR/STTR RPGS
Development of an NTSR1-Targeted Radiotherapeutic for Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2021 – 2026

Objective: More effective treatment options are needed across all clinical stages of colorectal cancer (CRC), from eliminating residual disease after surgery, improving surgical ca...

$3.22M
USD
Completed TRAINING, INDIVIDUAL
Investigating the role of EZH2 as a therapeutic target in colorectal cancers
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2023

Abstract The Polycomb Repressive Complex 2 (PRC2) is a highly conserved developmental regulator that maintains cellular identity by dynamically silencing key genes involved in diff...

$105.6K
USD
Completed TRAINING, INDIVIDUAL
Exploring the Role of Drp1 in Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2023

Abstract - Exploring the Role of Drp1 in Colorectal Cancer. Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Approximately 150,000 new c...

$151.9K
USD
Completed NON-SBIR/STTR RPGS
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY Relapse is the major cause of cancer related mortality in children with leukemia. Despite improvements in overall survival for children with B-cell progenitor acute...

$5.73M
USD
Completed TRAINING, INDIVIDUAL
Defining the regulation of UHRF1 and DNMT1 for maintenance of the epigenome
NATIONAL CANCER INSTITUTE Van Andel Research Institute United States 2021 – 2024

PROJECT SUMMARY In multicellular organisms, methylation of DNA on the 5’ carbon of cytosine helps ensure proper gene expression. Methylation occurs symmetrically on both DNA strand...

$717.9K
USD
Completed OTHER RESEARCH-RELATED
The Pediatric Advanced Cancer Experience (PACE): Measuring Quality of End-of-Life Care for Children with Cancer
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2026

PROJECT SUMMARY Although cure rates for childhood cancer have increased over several decades, cancer remains the leading cause of non-accidental death in children. Yet, there are n...

$2.2M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of adhesion and invasion in hyaluronic acid matrices
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Hyaluronic acid (HA) is the most abundant component of the human brain, where it serves essential structural, mechanical, and cell-instructive functions. A...

$3.51M
USD
Completed OTHER RESEARCH-RELATED
DNA Damage and Immunogenicity in Ewing Sarcoma
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

The goal of this career development award is for the applicant to expand her knowledge and technical expertise in tumor immunology and bioinformatic analyses in order to apply thes...

$1.53M
USD
Completed NON-SBIR/STTR RPGS
Estrogen receptor fusions genes as drivers of endocrine resistance in breast cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

Anti-estrogen therapy is key to the prevention and treatment of estrogen receptor (ER, ESR1) positive breast cancer, but therapy resistance occurs in up to a half of cases resultin...

$5.68M
USD
Completed NON-SBIR/STTR RPGS
Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

ABSTRACT Recent advances in chromatin conformation capture techniques have revolutionized our understanding of chro- matin organization and have provided novel insights at an unpre...

$6.05M
USD
Completed NON-SBIR/STTR RPGS
Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2026

N-methyltransferase (NNMT), a key enzyme in the NAD+ salvage pathway with unclear functions, is expressed highly and specifically in basal-like breast cancer (BLBC). We found that...

$3.86M
USD